bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Table S1 from Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets
Authors: Flanagan James M. , Funes Juan M. , Henderson Stephen , Wild Laurence , Carey Nessa , Boshoff Chris
Published: April 2023

Supplementary Table S1 from Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets
Supplementary Figure 2 from Silencing of Tubulin Binding Cofactor C Modifies Microtubule Dynamics and Cell Cycle Distribution and Enhances Sensitivity to Gemcitabine in Breast Cancer Cells
Authors: Hage-Sleiman Rouba , Herveau Stéphanie , Matera Eva-Laure , Laurier Jean-Fabien , Dumontet Charles
Published: April 2023

Supplementary Figure 2 from Silencing of Tubulin Binding Cofactor C Modifies Microtubule Dynamics and Cell Cycle Distribution and Enhances Sensitivity to Gemcitabine in Breast Cancer Cells
Supplementary Fig. S3 from Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion
Authors: Saunders Lauren P. , Ouellette Amy , Bandle Russ , Chang William Chozen , Zhou Hongwen , Misra Raj N. , De La Cruz Enrique M. , Braddock Demetrios T.
Published: April 2023

Supplementary Fig. S3 from Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion
Supplementary Fig. S2 from Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion
Authors: Saunders Lauren P. , Ouellette Amy , Bandle Russ , Chang William Chozen , Zhou Hongwen , Misra Raj N. , De La Cruz Enrique M. , Braddock Demetrios T.
Published: April 2023

Supplementary Fig. S2 from Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion
Supplementary Table 3 from Preclinical Studies on the Mechanism of Action and the Anti-Lymphoma Activity of the Novel Anti-CD20 Antibody GA101
Authors: Dalle Stephane , Reslan Lina , Besseyre de Horts Timothee , Herveau Stephanie , Herting Frank , Plesa Adriana , Friess Thomas , Umana Pablo , Klein Christian , Dumontet Charles
Published: April 2023

XLS - 27K, Supplementary Table 3
Supplementary Material from Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1
Authors: Blasina Alessandra , Hallin Jill , Chen Enhong , Arango Maria Elena , Kraynov Eugenia , Register James , Grant Stephan , Ninkovic Sacha , Chen Ping , Nichols Tim , O'Connor Patrick , Anderes Kenna
Published: April 2023

Supplementary Material from Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1
Supplementary Table 2 from Modulation of drug resistance by artificial transcription factors
Authors: Blancafort Pilar , Tschan Mario P. , Bergquist Sharon , Guthy Daniel , Brachat Arndt , Sheeter Dennis A. , Torbett Bruce E. , Erdmann Dirk , Barbas Carlos F.
Published: April 2023

Supplementary Table 2 from Modulation of drug resistance by artificial transcription factors
Supplementary Methods and Materials from Modulation of drug resistance by artificial transcription factors
Authors: Blancafort Pilar , Tschan Mario P. , Bergquist Sharon , Guthy Daniel , Brachat Arndt , Sheeter Dennis A. , Torbett Bruce E. , Erdmann Dirk , Barbas Carlos F.
Published: April 2023

Supplementary Methods and Materials from Modulation of drug resistance by artificial transcription factors
Supplementary Figure 3 from Modulation of drug resistance by artificial transcription factors
Authors: Blancafort Pilar , Tschan Mario P. , Bergquist Sharon , Guthy Daniel , Brachat Arndt , Sheeter Dennis A. , Torbett Bruce E. , Erdmann Dirk , Barbas Carlos F.
Published: April 2023

Supplementary Figure 3 from Modulation of drug resistance by artificial transcription factors
Supplementary Fig. S1 from UBE1L causes lung cancer growth suppression by targeting cyclin D1
Authors: Feng Qing , Sekula David , Guo Yongli , Liu Xi , Black Candice C. , Galimberti Fabrizio , Shah Sumit J. , Sempere Lorenzo F. , Memoli Vincent , Andersen Jesper B. , Hassel Bret A. , Dragnev Konstantin , Dmitrovsky Ethan
Published: April 2023

Supplementary Fig. S1 from UBE1L causes lung cancer growth suppression by targeting cyclin D1
Supplementary Table S1 from Proteomic characterization of cytoskeletal and mitochondrial class III β-tubulin
Authors: Cicchillitti Lucia , Penci Roberta , Di Michele Michela , Filippetti Flavia , Rotilio Domenico , Donati Maria Benedetta , Scambia Giovanni , Ferlini Cristiano
Published: April 2023

Supplementary Table S1 from Proteomic characterization of cytoskeletal and mitochondrial class III β-tubulin
Supplementary Figure 1 from Celecoxib Can Induce Vascular Endothelial Growth Factor Expression and Tumor Angiogenesis
Authors: Xu Kaiming , Gao Huiying , Shu Hui-Kuo G.
Published: April 2023

Supplementary Figure 1 from Celecoxib Can Induce Vascular Endothelial Growth Factor Expression and Tumor Angiogenesis
Supplementary Fig. from Overexpression of the dual specificity phosphatase, Cdc25C, confers sensitivity on tumor cells to doxorubicin-induced cell death
Authors: Varmeh Shohreh , Manfredi James J.
Published: April 2023

Supplementary Fig. from Overexpression of the dual specificity phosphatase, Cdc25C, confers sensitivity on tumor cells to doxorubicin-induced cell death
Supplementary Fig. S4 from Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor
Authors: Gonzales Andrea J. , Hook Kenneth E. , Althaus Irene W. , Ellis Paul A. , Trachet Erin , Delaney Amy M. , Harvey Patricia J. , Ellis Teresa A. , Amato Danielle M. , Nelson James M. , Fry David W. , Zhu Tong , Loi Cho-Ming , Fakhoury Stephen A. , Schlosser Kevin M. , Sexton Karen E. , Winters R. Thomas , Reed Jessica E. , Bridges Alex J. , Lettiere Daniel J. , Baker Deborah A. , Yang Jianxin , Lee Helen T. , Tecle Haile , Vincent Patrick W.
Published: April 2023

Supplementary Fig. S4 from Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor
Supplementary Figure Legends from Anticancer Activity of a Combination of Cisplatin and Fisetin in Embryonal Carcinoma Cells and Xenograft Tumors
Authors: Tripathi Rakshamani , Samadder Tanmoy , Gupta Sarika , Surolia Avadhesha , Shaha Chandrima
Published: April 2023

Supplementary Figure Legends from Anticancer Activity of a Combination of Cisplatin and Fisetin in Embryonal Carcinoma Cells and Xenograft Tumors
Supplementary Figure 8 from Anticancer Activity of a Combination of Cisplatin and Fisetin in Embryonal Carcinoma Cells and Xenograft Tumors
Authors: Tripathi Rakshamani , Samadder Tanmoy , Gupta Sarika , Surolia Avadhesha , Shaha Chandrima
Published: April 2023

Supplementary Figure 8 from Anticancer Activity of a Combination of Cisplatin and Fisetin in Embryonal Carcinoma Cells and Xenograft Tumors
Supplementary Fig. S3 from A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1α
Authors: Li Shan Hua , Shin Dong Hoon , Chun Yang-Sook , Lee Myung Kyu , Kim Myung-Suk , Park Jong-Wan
Published: April 2023

Supplementary Fig. S3 from A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1α
Legends for Supplementary Figures 1-2, Tables 1-6 from BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR
Authors: Carboni Joan M. , Wittman Mark , Yang Zheng , Lee Francis , Greer Ann , Hurlburt Warren , Hillerman Stephen , Cao Carolyn , Cantor Glenn H. , Dell-John Janet , Chen Cliff , Discenza Lorell , Menard Krista , Li Aixin , Trainor George , Vyas Dolatrai , Kramer Robert , Attar Ricardo M. , Gottardis Marco M.
Published: April 2023

Legends for Supplementary Figures 1-2, Tables 1-6 from BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR
Supplementary Fig. S4 from Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage
Authors: Krynetskaia Natalia F. , Phadke Manali S. , Jadhav Sachin H. , Krynetskiy Evgeny Y.
Published: April 2023

Supplementary Fig. S4 from Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage
Supplementary Fig. S3 from Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage
Authors: Krynetskaia Natalia F. , Phadke Manali S. , Jadhav Sachin H. , Krynetskiy Evgeny Y.
Published: April 2023

Supplementary Fig. S3 from Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage
Supplementary Fig. from Cell surface profiling with peptide libraries yields ligand arrays that classify breast tumor subtypes
Authors: Dane Karen Y. , Gottstein Claudia , Daugherty Patrick S.
Published: April 2023

Supplementary Fig. from Cell surface profiling with peptide libraries yields ligand arrays that classify breast tumor subtypes
Supplementary Fig. S1 from Cytotoxicity of the matrix metalloproteinase–activated anthrax lethal toxin is dependent on gelatinase expression and B-RAF status in human melanoma cells
Authors: Alfano Randall W. , Leppla Stephen H. , Liu Shihui , Bugge Thomas H. , Herlyn Meenhard , Smalley Keiran S. , Bromberg-White Jennifer L. , Duesbery Nicholas S. , Frankel Arthur E.
Published: April 2023

Supplementary Fig. S1 from Cytotoxicity of the matrix metalloproteinase–activated anthrax lethal toxin is dependent on gelatinase expression and B-RAF status in human melanoma cells
Supplementary Fig. S6 from Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor
Authors: Abouantoun Thamara J. , MacDonald Tobey J.
Published: April 2023

Supplementary Fig. S6 from Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor
Supplementary Fig. S5 from Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor
Authors: Abouantoun Thamara J. , MacDonald Tobey J.
Published: April 2023

Supplementary Fig. S5 from Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor
Supplementary Fig. S2 legend from Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cells
Authors: Kuo Po-Lin , Ni Wen-Chiu , Tsai Eing-Mei , Hsu Ya-Ling
Published: April 2023

Supplementary Fig. S2 legend from Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cells
Supplementary Fig. S2 from Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cells
Authors: Kuo Po-Lin , Ni Wen-Chiu , Tsai Eing-Mei , Hsu Ya-Ling
Published: April 2023

Supplementary Fig. S2 from Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cells
Supplementary Fig. S1 from Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor
Authors: Abouantoun Thamara J. , MacDonald Tobey J.
Published: April 2023

Supplementary Fig. S1 from Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor
Supplementary Fig. S1 legend from Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cells
Authors: Kuo Po-Lin , Ni Wen-Chiu , Tsai Eing-Mei , Hsu Ya-Ling
Published: April 2023

Supplementary Fig. S1 legend from Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cells
Supplementary Fig. S1 from Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cells
Authors: Kuo Po-Lin , Ni Wen-Chiu , Tsai Eing-Mei , Hsu Ya-Ling
Published: April 2023

Supplementary Fig. S1 from Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cells
Supplementary Fig. S1 from Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation
Authors: Zhou Jing , Lu Guo-Dong , Ong Chye-Sun , Ong Choon-Nam , Shen Han-Ming
Published: April 2023

Supplementary Fig. S1 from Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation
Supplementary Patient Data from Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
Authors: Weisberg Ellen , Choi Hwan Geun , Barrett Rosemary , Zhou Wenjun , Zhang Jianming , Ray Arghya , Nelson Erik A. , Jiang Jingrui , Moreno Daisy , Stone Richard , Galinsky Ilene , Fox Edward , Adamia Sophia , Kung Andrew L. , Gray Nathanael S. , Griffin James D.
Published: April 2023

Patient information corresponding to patients included in Supplementary Figure 5.
Supplementary Figure 8 from Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
Authors: Weisberg Ellen , Choi Hwan Geun , Barrett Rosemary , Zhou Wenjun , Zhang Jianming , Ray Arghya , Nelson Erik A. , Jiang Jingrui , Moreno Daisy , Stone Richard , Galinsky Ilene , Fox Edward , Adamia Sophia , Kung Andrew L. , Gray Nathanael S. , Griffin James D.
Published: April 2023

Supplementary Figure 8 from Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
Supplementary Data from Endocytosis of PEGylated Agents Enhances Cancer Imaging and Anticancer Efficacy
Authors: Chuang Kuo-Hsiang , Wang Hsin-Ell , Chen Fang-Ming , Tzou Shey-Cherng , Cheng Chiu-Min , Chang Ya-Chen , Tseng Wei-Lung , Shiea Jentaie , Lin Shiu-Ru , Wang Jaw-Yuan , Chen Bing-Mae , Roffler Steve R. , Cheng Tian-Lu
Published: April 2023

Supplementary Data from Endocytosis of PEGylated Agents Enhances Cancer Imaging and Anticancer Efficacy
Supplementary Figure 5A-5E from Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
Authors: Weisberg Ellen , Choi Hwan Geun , Barrett Rosemary , Zhou Wenjun , Zhang Jianming , Ray Arghya , Nelson Erik A. , Jiang Jingrui , Moreno Daisy , Stone Richard , Galinsky Ilene , Fox Edward , Adamia Sophia , Kung Andrew L. , Gray Nathanael S. , Griffin James D.
Published: April 2023

Supplementary Figure 5A-5E from Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
Supplementary Figure 4 from Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
Authors: Weisberg Ellen , Choi Hwan Geun , Barrett Rosemary , Zhou Wenjun , Zhang Jianming , Ray Arghya , Nelson Erik A. , Jiang Jingrui , Moreno Daisy , Stone Richard , Galinsky Ilene , Fox Edward , Adamia Sophia , Kung Andrew L. , Gray Nathanael S. , Griffin James D.
Published: April 2023

Supplementary Figure 4 from Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
Supplementary Figure 3A-3B from Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
Authors: Weisberg Ellen , Choi Hwan Geun , Barrett Rosemary , Zhou Wenjun , Zhang Jianming , Ray Arghya , Nelson Erik A. , Jiang Jingrui , Moreno Daisy , Stone Richard , Galinsky Ilene , Fox Edward , Adamia Sophia , Kung Andrew L. , Gray Nathanael S. , Griffin James D.
Published: April 2023

Supplementary Figure 3A-3B from Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
Supplementary Figure 2 from Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
Authors: Weisberg Ellen , Choi Hwan Geun , Barrett Rosemary , Zhou Wenjun , Zhang Jianming , Ray Arghya , Nelson Erik A. , Jiang Jingrui , Moreno Daisy , Stone Richard , Galinsky Ilene , Fox Edward , Adamia Sophia , Kung Andrew L. , Gray Nathanael S. , Griffin James D.
Published: April 2023

Supplementary Figure 2 from Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
Supplementary Figure 1 from Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
Authors: Weisberg Ellen , Choi Hwan Geun , Barrett Rosemary , Zhou Wenjun , Zhang Jianming , Ray Arghya , Nelson Erik A. , Jiang Jingrui , Moreno Daisy , Stone Richard , Galinsky Ilene , Fox Edward , Adamia Sophia , Kung Andrew L. , Gray Nathanael S. , Griffin James D.
Published: April 2023

Supplementary Figure 1 from Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
Video--post- vehicle tumor vascular area from Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models
Authors: Thompson Curtis B. , Shepard H. Michael , O'Connor Patrick M. , Kadhim Salam , Jiang Ping , Osgood Ryan J. , Bookbinder Louis H. , Li Xiaoming , Sugarman Barry J. , Connor Robert J. , Nadjsombati Sinisa , Frost Gregory I.
Published: April 2023

Video - 2-D ultrasound cine loop of post- vehicle tumor vascular area Vehicle at t = 8h; Mouse #413
Supplementary Data from Inhibition of type I histone deacetylase increases resistance of checkpoint-deficient cells to genotoxic agents through mitotic delay
Authors: Alao John P. , Olesch Jeanette , Sunnerhagen Per
Published: April 2023

Supplementary Data from Inhibition of type I histone deacetylase increases resistance of checkpoint-deficient cells to genotoxic agents through mitotic delay
Video--post- PEGPH20 tumor vascular area from Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models
Authors: Thompson Curtis B. , Shepard H. Michael , O'Connor Patrick M. , Kadhim Salam , Jiang Ping , Osgood Ryan J. , Bookbinder Louis H. , Li Xiaoming , Sugarman Barry J. , Connor Robert J. , Nadjsombati Sinisa , Frost Gregory I.
Published: April 2023

Video - 2-D ultrasound cine loop of post- PEGPH20 tumor vascular area 15 mg/kg PEGPH20 at t = 8h; Mouse #149
Video Legend from Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models
Authors: Thompson Curtis B. , Shepard H. Michael , O'Connor Patrick M. , Kadhim Salam , Jiang Ping , Osgood Ryan J. , Bookbinder Louis H. , Li Xiaoming , Sugarman Barry J. , Connor Robert J. , Nadjsombati Sinisa , Frost Gregory I.
Published: April 2023

Video Legend from Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models
Supplementary Data from IFNγ Restores Breast Cancer Sensitivity to Fulvestrant by Regulating STAT1, IFN Regulatory Factor 1, NF-κB, BCL2 Family Members, and Signaling to Caspase-Dependent Apoptosis
Authors: Ning Yanxia , Riggins Rebecca B. , Mulla Jennifer E. , Chung Haniee , Zwart Alan , Clarke Robert
Published: April 2023

Supplementary Data from IFNγ Restores Breast Cancer Sensitivity to Fulvestrant by Regulating STAT1, IFN Regulatory Factor 1, NF-κB, BCL2 Family Members, and Signaling to Caspase-Dependent Apoptosis
Supplementary Table S1 from Artemin-Stimulated Progression of Human Non–Small Cell Lung Carcinoma Is Mediated by BCL2
Authors: Tang Jian-Zhong , Kong Xiang-Jun , Kang Jian , Fielder Graeme C. , Steiner Michael , Perry Jo K. , Wu Zheng-Sheng , Yin Zhinan , Zhu Tao , Liu Dong-Xu , Lobie Peter E.
Published: April 2023

Table S1a: Expression of ARTN, GFRA2, GFRA3 and RET are compared between human lung carcinoma and normal lung tissues; Table S1b: Correlation between expression of ARTN and parameters of human lung carcinoma; Table S1c: Correlation between expression of GFRA1 and parameters of human lung carcinoma; Table S1d: Correlation between expression of GFRA2 and parameters of human lung carcinoma;Table S1e: Correlation between expression of GFRA3 and parameters of human lung carcinoma; Table S1f: Correlation between expression of RET and parameters of human lung carcinoma.
Supplementary Tables and Figure Legends from GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers
Authors: Sabbatini Peter , Korenchuk Susan , Rowand Jason L. , Groy Arthur , Liu Qi , Leperi Dominic , Atkins Charity , Dumble Melissa , Yang Jingsong , Anderson Kelly , Kruger Ryan G. , Gontarek Richard R. , Maksimchuk Kenneth R. , Suravajjala Sapna , Lapierre Russell R. , Shotwell J. Brad , Wilson Joseph W. , Chamberlain Stanley D. , Rabindran Sridhar K. , Kumar Rakesh
Published: April 2023

Supplementary Table 1. Kinase selectivity data for GSK1838705A
Supplementary Table 2 from Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design
Authors: Wei Ping , Walls Marlena , Qiu Ming , Ding Richard , Denlinger Robert H. , Wong Anthony , Tsaparikos Kosta , Jani Jitesh P. , Hosea Natilie , Sands Michelle , Randolph Sophia , Smeal Tod
Published: April 2023

Supplementary Table 2 from Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design
Supplementary Figure 6 from GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers
Authors: Sabbatini Peter , Korenchuk Susan , Rowand Jason L. , Groy Arthur , Liu Qi , Leperi Dominic , Atkins Charity , Dumble Melissa , Yang Jingsong , Anderson Kelly , Kruger Ryan G. , Gontarek Richard R. , Maksimchuk Kenneth R. , Suravajjala Sapna , Lapierre Russell R. , Shotwell J. Brad , Wilson Joseph W. , Chamberlain Stanley D. , Rabindran Sridhar K. , Kumar Rakesh
Published: April 2023

Supplementary Figure 6. Glucose metabolism after 8-day treatment of GSK1838705A.
Supplementary Figure 4 from GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers
Authors: Sabbatini Peter , Korenchuk Susan , Rowand Jason L. , Groy Arthur , Liu Qi , Leperi Dominic , Atkins Charity , Dumble Melissa , Yang Jingsong , Anderson Kelly , Kruger Ryan G. , Gontarek Richard R. , Maksimchuk Kenneth R. , Suravajjala Sapna , Lapierre Russell R. , Shotwell J. Brad , Wilson Joseph W. , Chamberlain Stanley D. , Rabindran Sridhar K. , Kumar Rakesh
Published: April 2023

Supplementary Figure 4. Effects of GSK1838705A on animal weights.
Supplementary Figure 1 from Histone Deacetylase Inhibition Attenuates Cell Growth with Associated Telomerase Inhibition in High-Grade Childhood Brain Tumor Cells
Authors: Rahman Ruman , Osteso-Ibanez Teresa , Hirst Robert A. , Levesley Jane , Kilday John-Paul , Quinn Siobhan , Peet Andrew , O'Callaghan Chris , Coyle Beth , Grundy Richard G.
Published: April 2023

Supplementary Figure 1 from Histone Deacetylase Inhibition Attenuates Cell Growth with Associated Telomerase Inhibition in High-Grade Childhood Brain Tumor Cells
Supplementary Figure 2 from GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers
Authors: Sabbatini Peter , Korenchuk Susan , Rowand Jason L. , Groy Arthur , Liu Qi , Leperi Dominic , Atkins Charity , Dumble Melissa , Yang Jingsong , Anderson Kelly , Kruger Ryan G. , Gontarek Richard R. , Maksimchuk Kenneth R. , Suravajjala Sapna , Lapierre Russell R. , Shotwell J. Brad , Wilson Joseph W. , Chamberlain Stanley D. , Rabindran Sridhar K. , Kumar Rakesh
Published: April 2023

Supplementary Figure 2. Representative cell cycle histograms from MCF-7 and NCIH929 cells treated with 1 μM of GSK1838705A for 48 h.
Supplementary Data from Nuclear factor κB inhibitors alleviate and the proteasome inhibitor PS-341 exacerbates radiation toxicity in zebrafish embryos
Authors: Daroczi Borbala , Kari Gabor , Ren Qing , Dicker Adam P. , Rodeck Ulrich
Published: April 2023

Supplementary Data from Nuclear factor κB inhibitors alleviate and the proteasome inhibitor PS-341 exacerbates radiation toxicity in zebrafish embryos
Supplementary Fig. S1 from Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E–mutated melanomas
Authors: Smalley Keiran S.M. , Lioni Mercedes , Palma Maurizia Dalla , Xiao Min , Desai Brijal , Egyhazi Suzanne , Hansson Johan , Wu Hong , King Alastair J. , Van Belle Patricia , Elder David E. , Flaherty Keith T. , Herlyn Meenhard , Nathanson Katherine L.
Published: April 2023

Supplementary Fig. S1 from Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E–mutated melanomas
Supplementary Table S1 from Elesclomol induces cancer cell apoptosis through oxidative stress
Authors: Kirshner Jessica R. , He Suqin , Balasubramanyam Vishwasenani , Kepros Jane , Yang Chin-Yu , Zhang Mei , Du Zhenjian , Barsoum James , Bertin John
Published: April 2023

Supplementary Table S1 from Elesclomol induces cancer cell apoptosis through oxidative stress
Supplementary Data from Systematic Interpretation of Comutated Genes in Large-Scale Cancer Mutation Profiles
Authors: Gu Yunyan , Yang Da , Zou Jinfeng , Ma Wencai , Wu Ruihong , Zhao Wenyuan , Zhang Yuannv , Xiao Hui , Gong Xue , Zhang Min , Zhu Jing , Guo Zheng
Published: April 2023

Supplementary Data from Systematic Interpretation of Comutated Genes in Large-Scale Cancer Mutation Profiles
Supplementary Material from Bortezomib induces apoptosis in esophageal squamous cell carcinoma cells through activation of the p38 mitogen-activated protein kinase pathway
Authors: Lioni Mercedes , Noma Kazuhiro , Snyder Andrew , Klein-Szanto Andres , Diehl J. Alan , Rustgi Anil K. , Herlyn Meenhard , Smalley Keiran S.M.
Published: April 2023

Supplementary Material from Bortezomib induces apoptosis in esophageal squamous cell carcinoma cells through activation of the p38 mitogen-activated protein kinase pathway
Supplementary Figures 1-3 from Oleandrin-mediated inhibition of human tumor cell proliferation: Importance of Na,K-ATPase α subunits as drug targets
Authors: Yang Peiying , Menter David G. , Cartwright Carrie , Chan Diana , Dixon Susan , Suraokar Milind , Mendoza Gabriela , Llansa Norma , Newman Robert A.
Published: April 2023

Supplementary Figures 1-3 from Oleandrin-mediated inhibition of human tumor cell proliferation: Importance of Na,K-ATPase α subunits as drug targets
Supplementary Table 3 from Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
Authors: Sun Feng , Chan Eli , Wu Zhenlong , Yang Xiaojing , Marquez Victor E. , Yu Qiang
Published: April 2023

Supplementary Table 3 from Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
Supplementary Fig. from Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance
Authors: Humeniuk Rita , Menon Lata G. , Mishra Prasun J. , Gorlick Richard , Sowers Rebecca , Rode Wojciech , Pizzorno Giuseppe , Cheng Yung-Chi , Kemeny Nancy , Bertino Joseph R. , Banerjee Debabrata
Published: April 2023

Supplementary Fig. from Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance
Supplementary Table 2 from Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
Authors: Sun Feng , Chan Eli , Wu Zhenlong , Yang Xiaojing , Marquez Victor E. , Yu Qiang
Published: April 2023

Supplementary Table 2 from Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
Supplementary Data from Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2
Authors: To Kenneth K.W. , Robey Robert W. , Knutsen Turid , Zhan Zhirong , Ried Thomas , Bates Susan E.
Published: April 2023

Supplementary Data from Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2
Supplementary Text from Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgen
Authors: Ariazi Eric A. , Leitão Andrei , Oprea Tudor I. , Chen Bin , Louis Teresa , Bertucci Anne Marie , Sharma Catherine G.N. , Gill Shaun D. , Kim Helen R. , Shupp Heather A. , Pyle Jennifer R. , Madrack Alexis , Donato Anne L. , Cheng Dong , Paige James R. , Jordan V. Craig
Published: April 2023

Supplementary Text from Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgen
Supplementary Figure 3 from Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
Authors: Sun Feng , Chan Eli , Wu Zhenlong , Yang Xiaojing , Marquez Victor E. , Yu Qiang
Published: April 2023

Supplementary Figure 3 from Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
Supplementary Figure 2 from Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
Authors: Sun Feng , Chan Eli , Wu Zhenlong , Yang Xiaojing , Marquez Victor E. , Yu Qiang
Published: April 2023

Supplementary Figure 2 from Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
Supplementary Fig. from A coordinated action of Bax, PUMA, and p53 promotes MG132-induced mitochondria activation and apoptosis in colon cancer cells
Authors: Ding Wen-Xing , Ni Hong-Min , Chen Xiaoyun , Yu Jian , Zhang Lin , Yin Xiao-Ming
Published: April 2023

Supplementary Fig. from A coordinated action of Bax, PUMA, and p53 promotes MG132-induced mitochondria activation and apoptosis in colon cancer cells
Supplementary Table S1 from EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line
Authors: Fukai Junya , Yokote Hideyuki , Yamanaka Ryuya , Arao Tokuzo , Nishio Kazuto , Itakura Toru
Published: April 2023

Supplementary Table S1 from EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line
Supplementary Table G from Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data
Authors: Petalidis Lawrence P. , Oulas Anastasis , Backlund Magnus , Wayland Matthew T. , Liu Lu , Plant Karen , Happerfield Lisa , Freeman Tom C. , Poirazi Panayiota , Collins V. Peter
Published: April 2023

Supplementary Table G from Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data
Supplementary Table S3 from Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid
Authors: Domhan Sophie , Muschal Stefan , Schwager Christian , Morath Christian , Wirkner Ute , Ansorge Wilhelm , Maercker Christian , Zeier Martin , Huber Peter E. , Abdollahi Amir
Published: April 2023

Supplementary Table S3 from Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid
Supplementary Information from Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data
Authors: Petalidis Lawrence P. , Oulas Anastasis , Backlund Magnus , Wayland Matthew T. , Liu Lu , Plant Karen , Happerfield Lisa , Freeman Tom C. , Poirazi Panayiota , Collins V. Peter
Published: April 2023

Supplementary Information from Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data
Supplementary Table Index from Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid
Authors: Domhan Sophie , Muschal Stefan , Schwager Christian , Morath Christian , Wirkner Ute , Ansorge Wilhelm , Maercker Christian , Zeier Martin , Huber Peter E. , Abdollahi Amir
Published: April 2023

Supplementary Table Index from Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid
Supplementary Table S3 from Comparison of antitumor effects of multitargeted tyrosine kinase inhibitors in acute myelogenous leukemia
Authors: Hu Shuiying , Niu Hongmei , Minkin Patton , Orwick Shelley , Shimada Akira , Inaba Hiroto , Dahl Gary V.H. , Rubnitz Jeffrey , Baker Sharyn D.
Published: April 2023

Supplementary Table S3 from Comparison of antitumor effects of multitargeted tyrosine kinase inhibitors in acute myelogenous leukemia
Supplementary Fig. S1 from AMG 479, a fully human anti–insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells
Authors: Beltran Pedro J. , Mitchell Petia , Chung Young-A , Cajulis Elaina , Lu John , Belmontes Brian , Ho Joanne , Tsai Mei Mei , Zhu Min , Vonderfecht Steven , Baserga Renato , Kendall Richard , Radinsky Robert , Calzone Frank J.
Published: April 2023

Supplementary Fig. S1 from AMG 479, a fully human anti–insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells
Supplementary Table 4 from Paclitaxel-Dependent Cell Lines Reveal a Novel Drug Activity
Authors: Ganguly Anutosh , Yang Hailing , Cabral Fernando
Published: April 2023

Supplementary Table 4 from Paclitaxel-Dependent Cell Lines Reveal a Novel Drug Activity
Supplementary Table 3 from Paclitaxel-Dependent Cell Lines Reveal a Novel Drug Activity
Authors: Ganguly Anutosh , Yang Hailing , Cabral Fernando
Published: April 2023

Supplementary Table 3 from Paclitaxel-Dependent Cell Lines Reveal a Novel Drug Activity
Supplementary Table 1 from miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation
Authors: Boni Valentina , Bitarte Nerea , Cristobal Ion , Zarate Ruth , Rodriguez Javier , Maiello Evaristo , Garcia-Foncillas Jesus , Bandres Eva
Published: April 2023

Supplementary Table 1 from miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation
Supplementary Table 1 from Paclitaxel-Dependent Cell Lines Reveal a Novel Drug Activity
Authors: Ganguly Anutosh , Yang Hailing , Cabral Fernando
Published: April 2023

Supplementary Table 1 from Paclitaxel-Dependent Cell Lines Reveal a Novel Drug Activity
Supplementary Figure 4 from miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation
Authors: Boni Valentina , Bitarte Nerea , Cristobal Ion , Zarate Ruth , Rodriguez Javier , Maiello Evaristo , Garcia-Foncillas Jesus , Bandres Eva
Published: April 2023

Supplementary Figure 4 from miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation
Supplementary Figure Legend from Paclitaxel-Dependent Cell Lines Reveal a Novel Drug Activity
Authors: Ganguly Anutosh , Yang Hailing , Cabral Fernando
Published: April 2023

Supplementary Figure Legend from Paclitaxel-Dependent Cell Lines Reveal a Novel Drug Activity
Supplementary Methods and Figure Legends from Sorafenib, a Multikinase Inhibitor, Enhances the Response of Melanoma to Regional Chemotherapy
Authors: Augustine Christina K. , Toshimitsu Hiroaki , Jung Sin-Ho , Zipfel Patricia A. , Yoo Jin S. , Yoshimoto Yasunori , Selim M. Angelica , Burchette James , Beasley Georgia M. , McMahon Nicole , Padussis James , Pruitt Scott K. , Ali-Osman Francis , Tyler Douglas S.
Published: April 2023

Supplementary Methods and Figure Legends from Sorafenib, a Multikinase Inhibitor, Enhances the Response of Melanoma to Regional Chemotherapy
Supplementary Data from Doxorubicin Resistance in a Novel In vitro Model of Human Pleomorphic Liposarcoma Associated with Alternative Lengthening of Telomeres
Authors: Mitchell Marcy A. , Johnson Jay E. , Pascarelli Kara , Beeharry Neil , Chiourea Maria , Gagos Sarantis , Lev Dina , von Mehren Margaret , Kipling David , Broccoli Dominique
Published: April 2023

Supplementary Data from Doxorubicin Resistance in a Novel In vitro Model of Human Pleomorphic Liposarcoma Associated with Alternative Lengthening of Telomeres
Supplementary Figure 1 from Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition
Authors: Breuleux Madlaina , Klopfenstein Matthieu , Stephan Christine , Doughty Cheryl A. , Barys Louise , Maira Saveur-Michel , Kwiatkowski David , Lane Heidi A.
Published: April 2023

Supplementary Figure 1 from Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition
Supplementary Figure 5 from Lipoxin A4 and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: The Role of Antiangiogenesis
Authors: Chen Ying , Hao Hua , He Songqing , Cai Lei , Li Yongsheng , Hu Shunze , Ye Duyun , Hoidal John , Wu Ping , Chen Xiaoping
Published: April 2023

Supplementary Figure 5 from Lipoxin A4 and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: The Role of Antiangiogenesis
Supplementary Data from Cisplatin Treatment Induces a Transient Increase in Tumorigenic Potential Associated with High Interleukin-6 Expression in Head and Neck Squamous Cell Carcinoma
Authors: Poth Kim J. , Guminski Alexander D. , Thomas Gethin P. , Leo Paul J. , Jabbar Ibtissam A. , Saunders Nicholas A.
Published: April 2023

Supplementary Data from Cisplatin Treatment Induces a Transient Increase in Tumorigenic Potential Associated with High Interleukin-6 Expression in Head and Neck Squamous Cell Carcinoma
Supplementary Figure 4 from Lipoxin A4 and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: The Role of Antiangiogenesis
Authors: Chen Ying , Hao Hua , He Songqing , Cai Lei , Li Yongsheng , Hu Shunze , Ye Duyun , Hoidal John , Wu Ping , Chen Xiaoping
Published: April 2023

Supplementary Figure 4 from Lipoxin A4 and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: The Role of Antiangiogenesis
Supplementary Fig. S5 from Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells
Authors: Weisberg Ellen , Wright Renee D. , McMillin Douglas W. , Mitsiades Constantine , Ray Arghya , Barrett Rosemary , Adamia Sophia , Stone Richard , Galinsky Ilene , Kung Andrew L. , Griffin James D.
Published: April 2023

Supplementary Fig. S5 from Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells
Supplementary Tables 1-4 from Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set
Authors: Park Eun Sung , Rabinovsky Rosalia , Carey Mark , Hennessy Bryan T. , Agarwal Roshan , Liu Wenbin , Ju Zhenlin , Deng Wanleng , Lu Yiling , Woo Hyun Goo , Kim Sang-Bae , Cheong Jae-Ho , Garraway Levi A. , Weinstein John N. , Mills Gordon B. , Lee Ju-Seog , Davies Michael A.
Published: April 2023

Supplementary Tables 1-4 from Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set
Supplementary Data from Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion
Authors: Golding Sarah E. , Rosenberg Elizabeth , Valerie Nicholas , Hussaini Isa , Frigerio Mark , Cockcroft Xiaoling F. , Chong Wei Yee , Hummersone Marc , Rigoreau Laurent , Menear Keith A. , O'Connor Mark J. , Povirk Lawrence F. , van Meter Timothy , Valerie Kristoffer
Published: April 2023

Supplementary Data from Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion
Supplementary Fig. S5 from In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies
Authors: Ogawa Mikako , Regino Celeste A.S. , Choyke Peter L. , Kobayashi Hisataka
Published: April 2023

Supplementary Fig. S5 from In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies
Supplementary Fig. S4 from Dual silencing of insulin-like growth factor-I receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis
Authors: Kaulfuβ Silke , Burfeind Peter , Gaedcke Jochen , Scharf Jens-Gerd
Published: April 2023

Supplementary Fig. S4 from Dual silencing of insulin-like growth factor-I receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis
Supplementary Table from Regulation of leukemic cell differentiation and retinoid-induced gene expression by statins
Authors: Sassano Antonella , Lo Iacono Marco , Antico Giovanni , Jordan Alison , Uddin Shahab , Calogero Raffaele A. , Platanias Leonidas C.
Published: April 2023

Supplementary Table from Regulation of leukemic cell differentiation and retinoid-induced gene expression by statins
Supplementary Table S6 from Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters
Authors: Okabe Mitsunori , Szakács Gergely , Reimers Mark A. , Suzuki Toshihiro , Hall Matthew D. , Abe Takaaki , Weinstein John N. , Gottesman Michael M.
Published: April 2023

Supplementary Table S6 from Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters
Supplementary Figure 6 from Identification of LIV1, a Putative Zinc Transporter Gene Responsible for HDACi-Induced Apoptosis, Using a Functional Gene Screen Approach
Authors: Ma Xiaoli , Ma Quanfu , Liu Jia , Tian Yuan , Wang Beibei , Taylor Kathryn M. , Wu Peng , Wang Daowen , Xu Gang , Meng Li , Wang Shixuan , Ma Ding , Zhou Jianfeng
Published: April 2023

Supplementary Figure 6 from Identification of LIV1, a Putative Zinc Transporter Gene Responsible for HDACi-Induced Apoptosis, Using a Functional Gene Screen Approach
Supplementary Figure 3 from Identification of LIV1, a Putative Zinc Transporter Gene Responsible for HDACi-Induced Apoptosis, Using a Functional Gene Screen Approach
Authors: Ma Xiaoli , Ma Quanfu , Liu Jia , Tian Yuan , Wang Beibei , Taylor Kathryn M. , Wu Peng , Wang Daowen , Xu Gang , Meng Li , Wang Shixuan , Ma Ding , Zhou Jianfeng
Published: April 2023

Supplementary Figure 3 from Identification of LIV1, a Putative Zinc Transporter Gene Responsible for HDACi-Induced Apoptosis, Using a Functional Gene Screen Approach
Supplementary Figure 1 from Identification of LIV1, a Putative Zinc Transporter Gene Responsible for HDACi-Induced Apoptosis, Using a Functional Gene Screen Approach
Authors: Ma Xiaoli , Ma Quanfu , Liu Jia , Tian Yuan , Wang Beibei , Taylor Kathryn M. , Wu Peng , Wang Daowen , Xu Gang , Meng Li , Wang Shixuan , Ma Ding , Zhou Jianfeng
Published: April 2023

Supplementary Figure 1 from Identification of LIV1, a Putative Zinc Transporter Gene Responsible for HDACi-Induced Apoptosis, Using a Functional Gene Screen Approach
Supplementary Fig. S1 from Antiangiogenic vinflunine affects EB1 localization and microtubule targeting to adhesion sites
Authors: Honoré Stéphane , Pagano Alessandra , Gauthier Géraldine , Bourgarel-Rey Véronique , Verdier-Pinard Pascal , Civiletti Karine , Kruczynski Anna , Braguer Diane
Published: April 2023

Supplementary Fig. S1 from Antiangiogenic vinflunine affects EB1 localization and microtubule targeting to adhesion sites
Supplementary Figure Legend from Decreased Survival of Human Breast Cancer Cells Expressing HER2/neu on In vitro Incubation with an Anti-HER2/neu Antibody Fused to C5a or C5adesArg
Authors: Fuenmayor Jaheli , Perez-Vazquez Karin , Perez-Witzke Daniel , Penichet Manuel L. , Montano Ramon F.
Published: April 2023

Supplementary Figure Legend from Decreased Survival of Human Breast Cancer Cells Expressing HER2/neu on In vitro Incubation with an Anti-HER2/neu Antibody Fused to C5a or C5adesArg
Supplementary Figure 1 from Decreased Survival of Human Breast Cancer Cells Expressing HER2/neu on In vitro Incubation with an Anti-HER2/neu Antibody Fused to C5a or C5adesArg
Authors: Fuenmayor Jaheli , Perez-Vazquez Karin , Perez-Witzke Daniel , Penichet Manuel L. , Montano Ramon F.
Published: April 2023

Supplementary Figure 1 from Decreased Survival of Human Breast Cancer Cells Expressing HER2/neu on In vitro Incubation with an Anti-HER2/neu Antibody Fused to C5a or C5adesArg
Supplementary Fig. S1 from Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-d-glucose under hypoxia in lung cancer cell lines
Authors: Wangpaichitr Medhi , Savaraj Niramol , Maher Johnathan , Kurtoglu Metin , Lampidis Theodore J.
Published: April 2023

Supplementary Fig. S1 from Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-d-glucose under hypoxia in lung cancer cell lines
Supplementary Fig. S1 from Eps8 decreases chemosensitivity and affects survival of cervical cancer patients
Authors: Chen Yun-Ju , Shen Meng-Ru , Chen Yen-Jen , Maa Ming-Chei , Leu Tzeng-Horng
Published: April 2023

Supplementary Fig. S1 from Eps8 decreases chemosensitivity and affects survival of cervical cancer patients
Supplementary Table 1 from Response prediction to a multitargeted kinase inhibitor in cancer cell lines and xenograft tumors using high-content tyrosine peptide arrays with a kinetic readout
Authors: Versele Matthias , Talloen Willem , Rockx Cindy , Geerts Tamara , Janssen Boud , Lavrijssen Tom , King Peter , Göhlmann Hinrich W.H. , Page Martin , Perera Tim
Published: April 2023

Supplementary Table 1 from Response prediction to a multitargeted kinase inhibitor in cancer cell lines and xenograft tumors using high-content tyrosine peptide arrays with a kinetic readout
Supplementary Fig. S6 from Rapamycin inhibits multiple stages of c-Neu/ErbB2–induced tumor progression in a transgenic mouse model of HER2-positive breast cancer
Authors: Mosley Jonathan D. , Poirier John T. , Seachrist Darcie D. , Landis Melissa D. , Keri Ruth A.
Published: April 2023

Supplementary Fig. S6 from Rapamycin inhibits multiple stages of c-Neu/ErbB2–induced tumor progression in a transgenic mouse model of HER2-positive breast cancer
Supplementary Table S1 from Nuclear factor-κB activation: a molecular therapeutic target for estrogen receptor–negative and epidermal growth factor receptor family receptor–positive human breast cancer
Authors: Singh Sindhu , Shi Qian , Bailey Shannon T. , Palczewski Marek J. , Pardee Arthur B. , Iglehart J. Dirk , Biswas Debajit K.
Published: April 2023

Supplementary Table S1 from Nuclear factor-κB activation: a molecular therapeutic target for estrogen receptor–negative and epidermal growth factor receptor family receptor–positive human breast cancer
Supplementary Fig. S1 from Nuclear factor-κB activation: a molecular therapeutic target for estrogen receptor–negative and epidermal growth factor receptor family receptor–positive human breast cancer
Authors: Singh Sindhu , Shi Qian , Bailey Shannon T. , Palczewski Marek J. , Pardee Arthur B. , Iglehart J. Dirk , Biswas Debajit K.
Published: April 2023

Supplementary Fig. S1 from Nuclear factor-κB activation: a molecular therapeutic target for estrogen receptor–negative and epidermal growth factor receptor family receptor–positive human breast cancer